Shanafelt Armen 4
4 · Surface Oncology, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Shanafelt Armen
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-07-01+6,937→ 6,937 totalExercise: $2.79Exp: 2029-07-01→ Common Stock (6,937 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer and committee fees of $11,875 which would have been paid quarterly. This option shall vest in full on September 30, 2019.